148 related articles for article (PubMed ID: 31563570)
1. Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model.
Campos EJ; Martins J; Brudzewsky D; Woldbye DPD; Ambrósio AF
Ann Anat; 2020 Jan; 227():151419. PubMed ID: 31563570
[TBL] [Abstract][Full Text] [Related]
2. Impact of type 1 diabetes mellitus and sitagliptin treatment on the neuropeptide Y system of rat retina.
Campos EJ; Martins J; Brudzewsky D; Correia S; Santiago AR; Woldbye DP; Ambrósio AF
Clin Exp Ophthalmol; 2018 Sep; 46(7):783-795. PubMed ID: 29442423
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis.
Kopp J; Nanobashvili A; Kokaia Z; Lindvall O; Hökfelt T
Brain Res Mol Brain Res; 1999 Sep; 72(1):17-29. PubMed ID: 10521595
[TBL] [Abstract][Full Text] [Related]
5. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence.
Zhang LP; Wang L
Acta Pharmacol Sin; 2005 Nov; 26(11):1290-6. PubMed ID: 16225749
[TBL] [Abstract][Full Text] [Related]
6. CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats treated with sitagliptin.
Coskun ZM; Koyuturk M; Karabulut S; Bolkent S
Pharmacol Rep; 2017 Aug; 69(4):822-829. PubMed ID: 28599244
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats.
Fu M; Li X; Zhang M; Xian Y
Chin Med J (Engl); 2002 May; 115(5):690-5. PubMed ID: 12133536
[TBL] [Abstract][Full Text] [Related]
9. Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus.
Madsen TM; Greisen MH; Nielsen SM; Bolwig TG; Mikkelsen JD
Neuroscience; 2000; 98(1):33-9. PubMed ID: 10858609
[TBL] [Abstract][Full Text] [Related]
10. Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection.
Gruber B; Greber S; Rupp E; Sperk G
Hippocampus; 1994 Aug; 4(4):474-82. PubMed ID: 7874238
[TBL] [Abstract][Full Text] [Related]
11. DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition.
Hubers SA; Wilson JR; Yu C; Nian H; Grouzmann E; Eugster P; Shibao CA; Billings FT; Jafarian Kerman S; Brown NJ
Hypertension; 2018 Sep; 72(3):712-719. PubMed ID: 29987109
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
[TBL] [Abstract][Full Text] [Related]
13. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
15. Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity.
Morgan DG; Lambert PD; Smith DM; Wilding JP; Bloom SR
J Neuroendocrinol; 1996 Apr; 8(4):283-90. PubMed ID: 8861284
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
[TBL] [Abstract][Full Text] [Related]
17. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy.
Furtinger S; Pirker S; Czech T; Baumgartner C; Ransmayr G; Sperk G
J Neurosci; 2001 Aug; 21(15):5804-12. PubMed ID: 11466452
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
J Neurochem; 2001 Oct; 79(2):286-96. PubMed ID: 11677256
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum.
Caberlotto L; Fuxe K; Hurd YL
J Chem Neuroanat; 2000 Dec; 20(3-4):327-37. PubMed ID: 11207429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
